Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne

Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne

Abstract Although natural products are essential sources of small‐molecule antitumor drugs, some can exert substantial toxicities, limiting their clinical utility. Anthraquinone‐fused enediyne natural products are remarkably potent antitumor drug candidates, and uncialamycin and tiancimycin (TNM) A...

Full description

Bibliographic Details
Main Authors: Xueqiong Feng, Zhongqing Wen, Xiangcheng Zhu, Xiaohui Yan, Yanwen Duan, Yong Huang
Format: Article
Language:English
Published: Wiley 2024-05-01
Series:Advanced Science
Subjects:
anthraquinone‐fused enediyne
breast cancer
immunoliposomes
tiancimycin A
trastuzumab
Online Access:https://doi.org/10.1002/advs.202307865

Internet

https://doi.org/10.1002/advs.202307865

Similar Items